Your browser doesn't support javascript.
loading
PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort.
Sherenian, M G; Cho, S H; Levin, A; Min, J-Y; Oh, S S; Hu, D; Galanter, J; Sen, S; Huntsman, S; Eng, C; Rodriguez-Santana, J R; Serebrisky, D; Avila, P C; Kalhan, R; Smith, L J; Borrell, L N; Seibold, M A; Keoki Williams, L; Burchard, E G; Kumar, R.
Afiliação
  • Sherenian MG; Division of Allergy-Immunology, Department of Pediatrics, Northwestern University, Chicago, IL, USA.
  • Cho SH; The Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Levin A; Division of Allergy-Immunology, Department of Medicine, Northwestern University, Chicago, IL, USA.
  • Min JY; Division of Allergy-Immunology, Department of Internal Medicine, University of South Florida, Tampa, FL, USA.
  • Oh SS; Department of Public Health Science, Henry Ford Health System, Detroit, MI, USA.
  • Hu D; Department of Otolaryngology, Northwestern University, Chicago, IL, USA.
  • Galanter J; Department of Medicine, University of California, San Francisco, CA, USA.
  • Sen S; Department of Medicine, University of California, San Francisco, CA, USA.
  • Huntsman S; Department of Medicine, University of California, San Francisco, CA, USA.
  • Eng C; Division of Biostatistics, Department of Preventive Medicine, UTHSC, Memphis, TN, USA.
  • Rodriguez-Santana JR; Department of Medicine, University of California, San Francisco, CA, USA.
  • Serebrisky D; Department of Medicine, University of California, San Francisco, CA, USA.
  • Avila PC; Centro de Neumologia Pediatrica, CSP, San Juan, PR, USA.
  • Kalhan R; Pediatric Pulmonary Division, Jacobi Medical Center, Bronx, NY, USA.
  • Smith LJ; Division of Allergy-Immunology, Department of Medicine, Northwestern University, Chicago, IL, USA.
  • Borrell LN; Division of Pulmonary Medicine, Department of Medicine, Northwestern University, Chicago, IL, USA.
  • Seibold MA; Division of Pulmonary Medicine, Department of Medicine, Northwestern University, Chicago, IL, USA.
  • Keoki Williams L; Department of Health Sciences, Lehman College, CUNY, New York, NY, USA.
  • Burchard EG; Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA.
  • Kumar R; Department of Internal Medicine, Henry Ford Health System, Detroit, MI, USA.
Clin Exp Allergy ; 47(9): 1150-1158, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28543872
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidor 1 de Ativador de Plasminogênio / Obstrução das Vias Respiratórias / Mutação com Ganho de Função Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidor 1 de Ativador de Plasminogênio / Obstrução das Vias Respiratórias / Mutação com Ganho de Função Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido